Additionally, metformin can significantly suppress the high expression of CCL19 and improve NAFLD, demonstrating that inhibition of CCL19 may be an effective treatment for NAFLD (41). The gene discussed is CCL19; the disease is metabolic dysfunction-associated steatotic liver disease.